Cross sensitization between the locomotor activating effects of the dopamine d2 agonists bromocriptine and quinpirole
Hoffman, D.C.; Wise, R.A.
Society for Neuroscience Abstracts 16(1): 438
1990
ISSN/ISBN: 0190-5295 Accession: 030748828
PDF emailed within 1 workday: $29.90
Related References
Hoffman, D.C.; Wise, R.A. 1993: Lack of cross-sensitization between the locomotor-activating effects of bromocriptine and those of cocaine or heroin Psychopharmacology 110(4): 402-408Johnson, E.F.; Szechtman, H. 2016: A dose-response study of separate and combined effects of the serotonin agonist 8-OH-DPAT and the dopamine agonist quinpirole on locomotor sensitization, cross-sensitization, and conditioned activity Behavioural Pharmacology 27(5): 439-450
Beerepoot, P.; Lam, V.; Luu, A.; Tsoi, B.; Siebert, D.; Szechtman, H. 2008: Effects of Salvinorin A on Locomotor Sensitization to D2/D3 Dopamine Agonist Quinpirole Neuroscience Letters 446(2-3): 101-104
Szechtman, H.; Dai, H.; Mustafa, S.; Einat, H.; Sullivan, R.M. 1994: Effects of dose and interdose interval on locomotor sensitization to the dopamine agonist quinpirole Pharmacology Biochemistry and Behavior 48(4): 921-928
Einat, H..; Szechtman, H.. 1993: Environmental modulation of both locomotor response and locomotor sensitization to the dopamine agonist quinpirole Behavioural Pharmacology 4(4): 399-403
Hoffman, D.C.; Wise, R.A. 1992: Locomotor-activating effects of the D2 agonist bromocriptine show environment-specific sensitization following repeated injections Psychopharmacology 107(2-3): 277-284
Galia Eshel; Svante, B. Ross; Diana Kelder; Lil, E. M. Edis; David, M. Jackson 1990: α1 (but not α2)-Adrenoceptor Agonists in Combination with the Dopamine D2 Agonist Quinpirole Produce Locomotor Stimulation in Dopamine-Depleted Mice Basic and Clinical Pharmacology and Toxicology 67(2): 123-131
Chiasson, K.; Daoust, B.ît.; Levesque, D.; Martinoli, M.-G. 2006: Dopamine D2 agonists, bromocriptine and quinpirole, increase MPP+ -induced toxicity in PC12 cells Neurotoxicity Research 10(1): 31-42
Hoffman, D.C.; Dickson, P.R.; Beninger, R.J. 1988: The dopamine D2 receptor agonists, quinpirole and bromocriptine produce conditioned place preferences Progress in Neuro-Psychopharmacology and Biological Psychiatry 12(2-3): 315-322
Einat, H.; Einat, D.; Allan, M.; Talangbayan, H.; Tsafnat, T.; Szechtman, H. 1996: Associational and nonassociational mechanisms in locomotor sensitization to the dopamine agonist quinpirole Psychopharmacology 127(2): 95-101
Lomanowska, A.; Gormley, S.; Szechtman, H. 2004: Presynaptic stimulation and development of locomotor sensitization to the dopamine agonist quinpirole Pharmacology Biochemistry and Behavior 77(3): 617-622
Messier, C.; Mrabet, O.; Destrabe, C. 1991: Cross sensitization between d1 and d2 dopamine agonists effect of a single intra accumbens injection on subsequent locomotor activity in mice Society for Neuroscience Abstracts 17(1-2): 611
Jolly, D.C.; Vezina, P. 1995: MK-801 blocks the development of sensitization to the locomotor and dopamine activating effects of amphetamine Society for Neuroscience Abstracts 21(1-3): 2089
Eshel, G.; Ross, S.B.; Kelder, D.; Edis, L.E.; Jackson, D.M. 1990: Alpha 1 (but not alpha 2)-adrenoceptor agonists in combination with the dopamine D2 agonist quinpirole produce locomotor stimulation in dopamine-depleted mice Pharmacology and Toxicology 67(2): 123-131
Culver, K.E.; Szechtman, H. 1999: The effect of intermittent and continuous clorgyline administration on locomotor sensitization induced by the dopamine agonist quinpirole Society for Neuroscience Abstracts 25(1-2): 1214
Fenu, S.; Cauli, O.; Morelli, M. 2000: Cross-sensitization between the motor activating effects of bromocriptine and caffeine: role of adenosine A(2A) receptors Behavioural Brain Research 114(1-2): 97-105
Perreault, M.L.; Graham, D.; Scattolon, S.; Wang, Y.; Szechtman, H.; Foster, J.A. 2007: Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats Psychopharmacology 194(4): 485-496
Jake Matthews, C.; Vezina, P. 1995: Cues specifically unpaired with amphetamine attenuate the development of locomotor sensitization to the D-2 dopamine receptor agonist quinpirole Society for Neuroscience Abstracts 21(1-3): 2089
Jung, T.D.; Jung, P.S.; Raveendran, L.; Farbod, Y.; Dvorkin-Gheva, A.; Sakic, B.; Surette, M.G.; Szechtman, H. 2018: Changes in gut microbiota during development of compulsive checking and locomotor sensitization induced by chronic treatment with the dopamine agonist quinpirole Behavioural Pharmacology 29(2 and 3-Spec Issue): 211-224
Muscat, R.; Iravani, M.M.; Kruk, Z.L. 1996: The role of ventral tegmental dopamine neurons in locomotor sensitization following quinpirole or (+)-amphetamine: ex vivo voltammetric evidence Neuroscience 75(4): 1175-1184